Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rascol

Showing results (81-90 of 220) with videos related to

Pageof 22
Sort By:
Clinical Neuropharmacology|February 1, 1994
Lacrimation in Parkinson's diseaseH Bagheri, M Berlan, J M Senard, et al.
Advances in Neurology|September 14, 2001
Dopamine agonists. Their role in the management of Parkinson's diseaseO Rascol, J J Ferreira, C Thalamas, et al.
Fundamental & Clinical Pharmacology|January 1, 1989
Effect of apomorphine on adrenal medullary catecholamine levelsJ L Montastruc, G Gaillard, O Rascol, et al.
Brain : a Journal of Neurology|August 17, 2002
Transmission of group II heteronymous pathways is enhanced in rigid lower limb of de novo patients with Parkinson's diseaseM Simonetta Moreau, S Meunier, M Vidailhet, et al.
Revue Neurologique|April 12, 2003
[Management of levodopa-induced dyskinesia]O. Rascol, J.-J. Ferreira, P. Payoux, et al.
European Journal of Clinical Pharmacology|July 29, 1999
Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's diseaseC Thalamas, A Taylor, C Brefel-Courbon, et al.
British Journal of Pharmacology|August 24, 1999
Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanismsE Lazartigues, C Brefel-Courbon, M A Tran, et al.
Therapie|September 1, 1994
[Drug-induced Parkinson syndrome: 10 years of drug vigilance]M E Llau, L Nguyen, J M Senard, et al.
Revue Neurologique|February 17, 2007
[Levodopa modifies pain thresholds in Parkinson's disease patients]T Slaoui, A Mas-Gerdelat, F Ory-Magne, et al.
Revue Neurologique|April 15, 2003
[Management of levodopa-induced dyskinesia]O Rascol, J J Ferreira, P Payoux, et al.
Pageof 22

Showing results (81-90 of 220) with videos related to

Sort By:
Pageof 22
Clinical Neuropharmacology|February 1, 1994
Lacrimation in Parkinson's diseaseH Bagheri, M Berlan, J M Senard, et al.
Advances in Neurology|September 14, 2001
Dopamine agonists. Their role in the management of Parkinson's diseaseO Rascol, J J Ferreira, C Thalamas, et al.
Fundamental & Clinical Pharmacology|January 1, 1989
Effect of apomorphine on adrenal medullary catecholamine levelsJ L Montastruc, G Gaillard, O Rascol, et al.
Brain : a Journal of Neurology|August 17, 2002
Transmission of group II heteronymous pathways is enhanced in rigid lower limb of de novo patients with Parkinson's diseaseM Simonetta Moreau, S Meunier, M Vidailhet, et al.
Revue Neurologique|April 12, 2003
[Management of levodopa-induced dyskinesia]O. Rascol, J.-J. Ferreira, P. Payoux, et al.
European Journal of Clinical Pharmacology|July 29, 1999
Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's diseaseC Thalamas, A Taylor, C Brefel-Courbon, et al.
British Journal of Pharmacology|August 24, 1999
Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanismsE Lazartigues, C Brefel-Courbon, M A Tran, et al.
Therapie|September 1, 1994
[Drug-induced Parkinson syndrome: 10 years of drug vigilance]M E Llau, L Nguyen, J M Senard, et al.
Revue Neurologique|February 17, 2007
[Levodopa modifies pain thresholds in Parkinson's disease patients]T Slaoui, A Mas-Gerdelat, F Ory-Magne, et al.
Revue Neurologique|April 15, 2003
[Management of levodopa-induced dyskinesia]O Rascol, J J Ferreira, P Payoux, et al.
Pageof 22